精选法规与标准美国 FDAT1077
FDA Issues Guidance to Improve Collection of Pregnancy Safety Data for Drugs and Biologics
🤖 AI 摘要
The U.S. Food and Drug Administration today issued a final guidance for industry, Postapproval Pregnancy Safety Studies, with recommendations on different methodologies that can be used in the postapproval setting to study the safety of drugs and biological products when used during pregnancy.
分析模型：rule-based-v3 · 07-09 06:59
评分详情
综合分 77/100
信源权威
95
影响范围
75
时效性
30
合规紧急
75
行业关注
75
FDA Press Releases (新闻发布)
操作：